Master of Pharmacy (MPharm) in Pharmaceutical Analysis and Quality Assurance

A. For Admission to M. Pharm. through GPAT Qualified Candidates :
Candidate should be an Indian National and who possess Bachelors degree or equivalent in Pharmacy from an AICTE approved institutions, with at least 55 % marks (at least 50% marks in case of SC/ST category & Physically Handicapped candidates belonging to Maharashtra State only) AND Should have valid and qualified GPAT score.
B. For Admission to M. Pharm. through MAH-MPH-CET Candidates:
Candidate should be an Indian National and who possess Bachelors degree or equivalent in Pharmacy from an AICTE approved institutions, with at least 55 % marks (at least 50% marks in case of SC/ST category & Physically Handicapped candidates belonging to Maharashtra State only) AND Should have Non zero Score in MAH-MPH-CET, if the candidate has neither appeared for GPAT nor having valid and qualified GPAT score.

• For Sponsored seats:
  The candidates who have minimum 2 years experience are only eligible for claiming sponsored seats. No reservation is available for SC / ST category for sponsored seats.
• Drugs being a very important component of healthcare, these need special attention especially with respect to quality, efficacy and safety. This has always been a matter of concern from the consumer point of view. The quality control concept basically meant that the quality of the product conformed to the predetermined standards as given in the pharmacopoeia.
• Responsibility of assuring product quality belongs principally to quality assurance personnel but involves team effort. The manufacturer fulfills his obligation to the consumer by following good manufacturing practices, which ensure that a product consistent high quality is manufactured by him every time.
• Good manufacturing starts from the time raw material enters the factory and continues into the final dosage form and takes care that it is delivered safely into the hands of consumer. In the recent past pharmaceutical manufacturing organizations world over have devoted a great deal of effort (resources) to ensure compliance with cGMP guidelines issued by licensing authorities.
• The Indian pharmaceutical industry in particular has demonstrated remarkably its ability to comply with the stringent requirements of regulatory authorities like the USFDA and UKMCA, etc. Still except for multinational companies and a few other pharmaceutical companies, GMP did not percolate to a large number of medium and small-scale pharmaceutical companies.